Innovid SEC Filings

Type
Report
Date
15-12G15-12G-Formular2/24/2025
EFFECTEFFECT-Formular2/21/2025
POS AMPOS AM-Formular2/21/2025
RWRW-Formular2/14/2025
S-8 POSS-8 POS-Formular2/14/2025
4Insidertransaktion2/14/2025
4Insidertransaktion2/13/2025
4Insidertransaktion2/13/2025
4Insidertransaktion2/13/2025
4Insidertransaktion2/13/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/13/2025
25-NSE25-NSE-Formular2/13/2025
4Insidertransaktion2/13/2025
4Insidertransaktion2/13/2025
SCHEDULE 13GSCHEDULE 13G-Formular2/11/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/11/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular2/5/2025
DEFA14ADEFA14A-Formular2/3/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/3/2025
SCHEDULE 13GSCHEDULE 13G-Formular1/30/2025
4Insidertransaktion1/23/2025
4Insidertransaktion1/21/2025
4Insidertransaktion1/21/2025
144144-Formular1/16/2025
144144-Formular1/16/2025
DEFM14ADEFM14A-Formular1/10/2025
4Insidertransaktion1/6/2025
4Insidertransaktion12/26/2024
PREM14APREM14A-Formular12/23/2024
4Insidertransaktion12/4/2024
144144-Formular12/2/2024
DEFA14ADEFA14A-Formular11/21/2024
DEFA14ADEFA14A-Formular11/21/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/21/2024
DEFA14ADEFA14A-Formular11/21/2024
DEFA14ADEFA14A-Formular11/21/2024
DEFA14ADEFA14A-Formular11/21/2024
8-K/A8-K/A-Formular11/21/2024
SC 13G/ABeneficial ownership report11/14/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/12/2024
10-QQuartalsbericht11/12/2024
4Insidertransaktion10/22/2024
4Insidertransaktion10/18/2024
4Insidertransaktion10/18/2024
144144-Formular10/16/2024
144144-Formular10/16/2024
144144-Formular10/16/2024
4Insidertransaktion10/3/2024
8-K/A8-K/A-Formular9/18/2024
4Insidertransaktion9/5/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/3/2024
4Insidertransaktion8/8/2024
4Insidertransaktion8/8/2024
4Insidertransaktion8/8/2024
10-QQuartalsbericht8/6/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/6/2024
SC 13GSC 13G-Formular8/1/2024
SC 13G/ABeneficial ownership report6/25/2024
4Insidertransaktion6/11/2024
4Insidertransaktion6/11/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/11/2024
4Insidertransaktion6/11/2024
4Insidertransaktion6/11/2024
4Insidertransaktion6/5/2024
144144-Formular6/3/2024
SC 13GSC 13G-Formular5/28/2024
4Insidertransaktion5/24/2024
SC 13G/ABeneficial ownership report5/24/2024
4Insidertransaktion5/23/2024
4Insidertransaktion5/22/2024
144144-Formular5/22/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/7/2024
10-QQuartalsbericht5/7/2024
DEFA14ADEFA14A-Formular4/30/2024
DEF 14ADEF 14A-Formular4/29/2024
4Insidertransaktion4/17/2024
4Insidertransaktion4/17/2024
4Insidertransaktion4/17/2024
4Insidertransaktion4/17/2024
4Insidertransaktion4/11/2024
4Insidertransaktion4/11/2024
SC 13G/ABeneficial ownership report4/1/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/12/2024
4Insidertransaktion3/1/2024
10-KJahresbericht2/29/2024
4Insidertransaktion2/29/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/27/2024
SC 13G/ABeneficial ownership report2/13/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/5/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/30/2023
4Insidertransaktion11/24/2023
4Insidertransaktion11/22/2023
4Insidertransaktion11/21/2023
4Insidertransaktion11/13/2023
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/8/2023
10-QQuartalsbericht11/8/2023
4Insidertransaktion10/20/2023
33-Formular10/20/2023
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/16/2023
EFFECTEFFECT-Formular9/19/2023

Innovid Documents 2026

This page contains all official documents and SEC filings for Innovid stock (CTV, ISIN: US4576791085). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Innovid's regulatory filings.

Innovid Stock analysis

Innovid Innovid Corp. generates revenue through its independent software platform providing ad serving, measurement, and creative services for TV ads across connected TV, mobile TV, and desktop TV environments. The company serves advertisers such as Anheuser-Busch InBev, CVS Pharmacy, Kellogg’s, Mercedes-Benz, Target, Sanofi, and Volvo, offering Campaign Submission Form, Campaign Management Tool, and Analytics Dashboard as core products. These tools enable clients to submit campaign details, manage implementations, and visualize performance metrics like audience reach and viewability. Additionally, Innovid provides Adobe and Google Web Designer plug-ins to enhance ad creation and data integration for its clients. The primary buyers of Innovid's services are TV advertisers, publishers, and media agencies seeking to create, deliver, and measure TV ad campaigns across digital platforms. Advertisers like Kellogg’s and Mercedes-Benz utilize the Campaign Management Tool for campaign implementation, while media agencies rely on the Analytics Dashboard for unified performance visualization. The firm's product suite targets the connected TV and digital advertising segments, focusing on precision measurement and streamlined campaign execution. Innovid’s revenue streams are derived from subscription-based access to its platform tools, including the Campaign Submission Form, Campaign Management Tool, and Analytics Dashboard, as well as the sale of Adobe and Google Web Designer plug-ins. These products cater to the needs of advertisers and agencies managing TV ad campaigns across multiple digital environments, ensuring efficient delivery and measurable results. The company’s offerings are tailored to meet the demands of major brands and media partners within the digital advertising ecosystem.